Literature DB >> 25824655

Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.

Anders Hjerpe1, Valeria Ascoli, Carlos W M Bedrossian, Mathilde E Boon, Jenette Creaney, Ben Davidson, Annika Dejmek, Katalin Dobra, Ambrogio Fassina, Andrew Field, Pinar Firat, Toshiaki Kamei, Tadao Kobayashi, Claire W Michael, Sevgen Önder, Amanda Segal, Philippe Vielh.   

Abstract

OBJECTIVE: To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma. DATA SOURCES: Cytopathologists with an interest in the field involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC) contributed to this update. Reference material includes peer-reviewed publications and textbooks. RATIONALE: This article is the result of discussions during and after the IMIG 2012 conference in Boston, followed by thorough discussions during the 2013 IAC meeting in Paris. Additional contributions have been obtained from cytopathologists and scientists who could not attend these meetings, with final discussions and input during the IMIG 2014 conference in Cape Town.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25824655     DOI: 10.1159/000377697

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  7 in total

Review 1.  Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.

Authors:  Marika Cinausero; Karim Rihawi; Francesca Sperandi; Barbara Melotti; Andrea Ardizzoni
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

2.  Cytological Diagnostic Procedures in Malignant Mesothelioma.

Authors:  Christian Biancosino; Lea Isabell Shari van der Linde; Guido Sauter; Florian Stellmacher; Marcus Krüger; Lutz Welker
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.

Authors:  Jenette Creaney; Ian M Dick; Justine S Leon; Bruce W S Robinson
Journal:  Cancer Genomics Proteomics       Date:  2017 Mar-Apr       Impact factor: 4.069

Review 4.  Modern management of malignant pleural mesothelioma.

Authors:  Shivani C Patel; Jonathan E Dowell
Journal:  Lung Cancer (Auckl)       Date:  2016-05-03

5.  Cytoskeletal Organization Correlates to Motility and Invasiveness of Malignant Mesothelioma Cells.

Authors:  Maureen Keller; Katarina Reis; Anders Hjerpe; Katalin Dobra; Pontus Aspenström
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

6.  Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway.

Authors:  Ana I Robles; Karina Standahl Olsen; Dana W T Tsui; Vassilis Georgoulias; Jenette Creaney; Katalin Dobra; Mogens Vyberg; Nagahiro Minato; Robert A Anders; Anne-Lise Børresen-Dale; Jianwei Zhou; Pål Sætrom; Boye Schnack Nielsen; Michaela B Kirschner; Hans E Krokan; Vassiliki Papadimitrakopoulou; Ioannis Tsamardinos; Oluf D Røe
Journal:  J Transl Med       Date:  2016-10-19       Impact factor: 5.531

7.  Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesothelioma.

Authors:  Takuya Watanabe; Katsuhiro Okuda; Takayuki Murase; Satoru Moriyama; Hiroshi Haneda; Osamu Kawano; Keisuke Yokota; Tadashi Sakane; Risa Oda; Hiroshi Inagaki; Ryoichi Nakanishi
Journal:  Oncotarget       Date:  2018-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.